Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success.
Belperio PS1, Chartier M2, Gonzalez RI3, Park AM4, Ross DB2, Morgan TR5, Backus LI6.
PMID: 29778256 DOI: 10.1016/j.idc.2018.02.011
Article shared by Henry E. Chang via Twitter
Link
Veterans Direct-acting antiviral SVR Hepatitis C Population health Innovation System redesign
KEY POINTS
Since January 2014 the Department of Veterans Affairs (VA) has made significant progress in the treatment of veterans with hepatitis C virus (HCV) and, as of December 2017, more than 100,000 veterans have been treated.
Special regional multidisciplinary Hepatitis C Innovation Teams were created that used lean process improvement and system redesign, resulting in innovative hepatitis C practice models that help to address gaps in care.
The VA has expanded access and treatment capacity for HCV-infected veterans through the use of nonphysician providers (clinical pharmacists, nurse practitioners, and physician assistants), video telehealth, and electronic technologies.
The VA continues to use population health management tools to effectively manage and track the treatment and care of veterans with HCV.
Abstract
The Department of Veterans Affairs (VA) has made significant progress in treating hepatitis C virus, experiencing more than a 75% reduction in veterans remaining to be treated since the availability of oral direct-acting antivirals. Hepatitis C Innovation Teams use lean process improvement and system redesign, resulting in practice models that address gaps in care. The key to success is creative improvements in veteran access to providers, including expanded use of nonphysician providers, video telehealth, and electronic technologies. Population health management tools monitor and identify trends in care, helping the VA tailor care and address barriers.Continue reading: https://jumpshare.com/v/mthQnTLKcsJETo8vlxug
No comments:
Post a Comment